$RGNX REGENXBIO Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in REGENXBIO Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in REGENXBIO Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in REGENXBIO Inc. for free.

CIK Number: 0001590877
IRS Number: 471851754
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: RGNX
Company Address: 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE 20850
Phone number: 240-552-8181
Former name: REGENXBIO, Inc., date of change: 2015-01-16
Former name: ReGenX Biosciences, LLC, date of change: 2013-11-01

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Market Capitalization: $465.96M
Prev close: $17.15
Average Daily Volume: 221,868
Days Low: $16.85
Year Low: $7.07
Year High: $24.55

REGENXBIO Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Christmas Patrick J.SVP, General Counsel3,00651,553shares bought: 71,865 / shares sold: -70,000 BUYJan 07 20192 months ago
Danos OlivierChief Scientific Officer6,500111,475shares bought: 26,500 / shares sold: -20,000 BUYMar 14 20198 days ago
Mills Kenneth T.President and CEO261,0004,476,150shares bought: 548,530 / shares sold: -297,970 STRONG BUYMar 21 2019yesterday
Simpson CurranSVP, Product Development & CTO44,800768,320shares bought: 262,823 / shares sold: -223,323 BUYFeb 27 201923 days ago
Vasista VittalChief Financial Officer239,2154,102,537shares bought: 315,701 / shares sold: -183,826 STRONG BUYMar 07 201915 days ago

View all REGENXBIO Inc. insiders.

REGENXBIO Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 21 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOOption ExerciseM0.8515,00012,750159,670
Mar 21 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS58.749,130536,296246,000255.1 K to 246 K (-3.58 %)
Mar 21 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS58.215,870341,693255,130261 K to 255.1 K (-2.25 %)
Mar 21 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOBuyM0.8515,00012,750261,000246 K to 261 K (+6.10 %)
Mar 14 2019RGNXREGENXBIO Inc.Danos OlivierChief Scientific Of ...Option ExerciseM20.355,000101,75073,500
Mar 14 2019RGNXREGENXBIO Inc.Danos OlivierChief Scientific Of ...BuyM20.355,000101,7506,5001.5 K to 6.5 K (+333.33 %)
Mar 07 2019RGNXREGENXBIO Inc.Vasista VittalChief Financial Off ...SellS60.013,068184,111239,215242.3 K to 239.2 K (-1.27 %)
Feb 27 2019RGNXREGENXBIO Inc.Simpson CurranSVP, Product Develo ...Option ExerciseM35.805,300189,74041,250
Feb 27 2019RGNXREGENXBIO Inc.Simpson CurranSVP, Product Develo ...SellS54.055,300286,46539,50044.8 K to 39.5 K (-11.83 %)
Feb 27 2019RGNXREGENXBIO Inc.Simpson CurranSVP, Product Develo ...BuyM35.805,300189,74044,80039.5 K to 44.8 K (+13.42 %)
Feb 19 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOOption ExerciseM0.8515,00012,750174,670
Feb 19 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS47.848,066385,877246,000254.1 K to 246 K (-3.17 %)
Feb 19 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS47.303,522166,591254,066257.6 K to 254.1 K (-1.37 %)
Feb 19 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS45.963,412156,816257,588261 K to 257.6 K (-1.31 %)
Feb 19 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOBuyM0.8515,00012,750261,000246 K to 261 K (+6.10 %)

View all REGENXBIO Inc. insider transactions.